Permsuwan, U., Dilokthornsakul, P., Thavorn, K., Saokaew, S., & Chaiyakunapruk, N. (2018). Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand.
Chicago Style CitationPermsuwan, Unchalee, Piyameth Dilokthornsakul, Kednapa Thavorn, Surasak Saokaew, and Nathorn Chaiyakunapruk. Cost-effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy Versus Sulfonylurea Monotherapy for People With Type 2 Diabetes and Chronic Kidney Disease in Thailand. 2018.
MLA引文Permsuwan, Unchalee, et al. Cost-effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy Versus Sulfonylurea Monotherapy for People With Type 2 Diabetes and Chronic Kidney Disease in Thailand. 2018.